THOMAS EDWARD KOWALSKI

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology PHILA, PA NPI 1952360596

General Payments — all program years on this page

$64,385.40

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 137
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,136.84 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $9,506.7232
2019 $6,977.7212
2020 $284.017
2021 $29,509.7828
2022 $6,595.8921
2023 $8,374.4422
2024 $3,136.8415

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092324145 Boston Scientific Corporation $5.51 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324147 Boston Scientific Corporation $22.63 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324149 Boston Scientific Corporation $38.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324151 Boston Scientific Corporation $39.53 10/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092324153 Boston Scientific Corporation $43.94 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324155 Boston Scientific Corporation $86.23 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324157 Boston Scientific Corporation $100.00 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324159 Boston Scientific Corporation $121.39 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324161 Boston Scientific Corporation $157.87 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092324163 Boston Scientific Corporation $500.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1092324165 Boston Scientific Corporation $750.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1092324167 Boston Scientific Corporation $1,000.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1108476476 Olympus America Inc. $22.30 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119562604 Medtronic, Inc. $209.30 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146124862 FUJIFILM Healthcare Americas Corporation $39.25 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.